Evaluation of Drug Lags in Development Initiation, New Drug Application and Approval Between Japan and the USA and the Impact of Local Versus Multi-regional Clinical Trials.

MLA

Ushijima, Satoshi, et al. “Evaluation of Drug Lags in Development Initiation, New Drug Application and Approval Between Japan and the USA and the Impact of Local Versus Multi-Regional Clinical Trials.” Pharmaceutical Medicine, vol. 35, no. 4, July 2021, pp. 253–60. EBSCOhost, https://doi.org/10.1007/s40290-021-00393-w.

APA

Ushijima, S., Matsumaru, N., & Tsukamoto, K. (2021). Evaluation of Drug Lags in Development Initiation, New Drug Application and Approval Between Japan and the USA and the Impact of Local Versus Multi-regional Clinical Trials. Pharmaceutical Medicine, 35(4), 253–260. https://doi.org/10.1007/s40290-021-00393-w

Chicago

Ushijima, Satoshi, Naoki Matsumaru, and Katsura Tsukamoto. 2021. “Evaluation of Drug Lags in Development Initiation, New Drug Application and Approval Between Japan and the USA and the Impact of Local Versus Multi-Regional Clinical Trials.” Pharmaceutical Medicine 35 (4): 253–60. doi:10.1007/s40290-021-00393-w.